CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Primient, a global leader in biomanufacturing and plant-based ingredients, announced today the creation of a new Biosolutions business unit to accelerate growth in ...
The AP released its All-American team on Tuesday, and headlining the list was Duke star Cameron Boozer. The presumptive Naismith Player of the Year favorite was the only player who earned unanimous ...
A number of conferences have finished their regular season and are beginning Champ Week. For most of the teams in the AP poll, however, league tournaments begin next week, giving us over seven more ...
(RTTNews) - Upstream Bio (UPB) will host a webcast today to present top-line results from its Phase 2 VALIANT trial evaluating Verekitug, a first-in-class antagonist of the thymic stromal ...
Feb 4 (Reuters) - Biotech firm Bio-Techne (TECH.O), opens new tab beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug ...
Arizona's win over Arizona State improved the Wildcats to 22-0, their best start in school history. Chris Coduto / Getty Images Arizona continues to win. And it continues to maintain a firm hold on ...
Tinlarebant reduces vitamin A-based toxins, targeting retinal disease progression in STGD1 and geographic atrophy. The DRAGON II trial is a global, 24-month, placebo-controlled study with 60 ...
Oh, AP style. You’re occasionally confusing but overall OK (not “okay”). Love it or loathe it, The Associated Press Stylebook is the lingua franca of written journalism. It’s why we say adviser, not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results